BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramírez E, Urroz M, Rodríguez A, González-Muñoz M, Martín-Vega A, Villán Y, Seco E, Monserrat J, Frías J, Carcas AJ, Borobia AM. Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.Front Pharmacol. 2020;11:602841. [PMID: 33343374 DOI: 10.3389/fphar.2020.602841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
2 Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Front Pharmacol 2022;13:835136. [DOI: 10.3389/fphar.2022.835136] [Reference Citation Analysis]
3 Al-shehail B, Al Jamea Z, Chacko R, Alotaibi F, Ismail N, Alshayban D. Incidence and Risk Factors of Adverse Drug Reactions in Patients with Coronavirus Disease 2019: A Pharmacovigilance Experience Utilizing An ADR Trigger Tool. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.01.021] [Reference Citation Analysis]